{"description":"AE that newly appears, increases in frequency, or worsens in severity following initiation of study drug and through the last study visit or up to 30 days after date of last dose, whichever is later.","eventGroups":[{"deathsNumAffected":1,"deathsNumAtRisk":80,"description":"NEOD001, 24 mg/kg IV every 4 weeks for 36 months","id":"EG000","otherNumAffected":28,"otherNumAtRisk":80,"seriousNumAffected":13,"seriousNumAtRisk":80,"title":"NEOD001 24 mg/kg"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA19.0 Hierarchy","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":80}],"term":"Upper respiratory tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA19.0 Hierarchy","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":80}],"term":"Fatigue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA19.0 Hierarchy","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":80}],"term":"Oedema peripheral"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA19.0 Hierarchy","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":80}],"term":"Arthralgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA19.0 Hierarchy","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":80}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA19.0 Hierarchy","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":80}],"term":"Headache"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA19.0 Hierarchy","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":80}],"term":"Device related infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA19.0 Hierarchy","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":80}],"term":"Endocarditis bacterial"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA19.0 Hierarchy","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":80}],"term":"Influenza"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA19.0 Hierarchy","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":80}],"term":"Lung Infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA19.0 Hierarchy","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":80}],"term":"Pneumonia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA19.0 Hierarchy","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":80}],"term":"Sepsis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA19.0 Hierarchy","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":80}],"term":"Septic embolus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA19.0 Hierarchy","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":80}],"term":"Atrial fibrillation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA19.0 Hierarchy","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":80}],"term":"Cardiac failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA19.0 Hierarchy","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":80}],"term":"Fluid overload"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA19.0 Hierarchy","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":80}],"term":"Hyponatraemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA19.0 Hierarchy","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":80}],"term":"Cerebrovascular accident"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA19.0 Hierarchy","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":80}],"term":"Gastrointestinal angiodysplasia haemorrhagic"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA19.0 Hierarchy","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":80}],"term":"Contusion"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA19.0 Hierarchy","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":80}],"term":"Pneumothorax"}],"timeFrame":"Initiation of study drug through study completion, up to 11 months"}